Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Germany(1,582/week)
    • France(1,186/week)
    • Poland(610/week)
    • Spain(568/week)
    • Italy(301/week)
    • View all (7,177/week)
  • News
    • United States(1736/week)
    • Manufacturing(877/week)
    • Energy(591/week)
    • Technology(1589/week)
    • Other Manufacturing(666/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Relmada Therapeutics, Inc.

Feb 23, 2021
Relmada Therapeutics Announces Participation in the 2021 SVB Leerink Global Healthcare Conference
Dec 07, 2020
Relmada Therapeutics Announces Initiation of Phase 3 Program for REL-1017 as Adjunctive Treatment for Patients with Major Depressive Disorder
Nov 17, 2020
Relmada Therapeutics to Participate in Upcoming Investor Conferences
Jul 13, 2020
Relmada Therapeutics Announces Uplisting to the Nasdaq Global Select Market®
Jun 23, 2020
Relmada Therapeutics Announces Notice of Allowance for Patent in Canada Covering REL-1017 for Treatment of Psychiatric Symptoms
May 27, 2020
Relmada Therapeutics Announces Outcome of End-of-Phase 2 Meeting with FDA for REL-1017 for Adjunctive Treatment of Patients with Major Depressive Disorder
Apr 28, 2020
Relmada Therapeutics Enhances Senior Leadership Team with Appointment of Brian A. Walter, Ph.D., as Vice President of Regulatory Affairs
Mar 31, 2020
Relmada Therapeutics Solidifies its R&D Leadership Team with the Appointment of Marc de Somer, MD, MBA, ScD, MPH, MSc, as Senior Vice President, Clinical Development and Safety
Mar 24, 2020
Relmada Therapeutics Strengthens Scientific Leadership Team with the Appointment of Judy Caron, Ph.D., as Vice President of Drug Development
Feb 25, 2020
Relmada Therapeutics to Present at 9th Annual SVB Leerink Global Healthcare Conference
Jan 10, 2020
Relmada Therapeutics Strengthens Financial Operations with Addition of Maged Shenouda as Chief Financial Officer
Dec 20, 2019
Relmada Therapeutics Strengthens Board of Directors with Appointments of Life Sciences Industry Veterans, Eric Schmidt, Ph.D., and John Glasspool
Dec 09, 2019
Relmada Therapeutics Announces Closing of $115 Million Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Dec 03, 2019
Relmada Therapeutics Announces Pricing of Public Offering of Common Stock
Dec 03, 2019
Relmada Therapeutics Announces Proposed Public Offering of Common Stock
Nov 19, 2019
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Relmada Therapeutics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
Oct 17, 2019
Relmada to Ring NASDAQ Stock Market Opening Bell on Friday, October 18
Oct 15, 2019
Relmada Therapeutics Announces Top-Line Results from REL-1017 Phase 2 Study in Individuals with Treatment Resistant Depression
Oct 14, 2019
Relmada Therapeutics to Announce Results of Phase 2 Study of REL-1017 for Treatment Resistant Depression and Conduct Conference Call on Tuesday, October 15
Oct 10, 2019
Relmada Therapeutics Announces Commencement of Trading on The NASDAQ Capital Market
  •  
  • Page 1
  • ››

Latest News

Feb 27, 2021

Teledyne to Hold Investor Meetings

Feb 27, 2021

Berry Global Group, Inc. Announces Pricing of Private Placement Notes Offering

Feb 27, 2021

Clearwater Paper Announces Virtual Participation at the J.P. Morgan 2021 Global High Yield & Leveraged...

Feb 27, 2021

NOTICE TO DISREGARD - Top Aces Corp.

Feb 27, 2021

ICL to Participate in Fireside Chat at Bank of America’s Global Agriculture and Materials Conference

Feb 27, 2021

USA Compression Partners, LP to Participate in Investor Conferences

Feb 27, 2021

Orion Engineered Carbons Announces Its 2021 Annual General Meeting Date and Record Date for the Annual...

Feb 27, 2021

Greenlane Renewables Announces Appointment of Olympia Trust Company as Transfer Agent and Registrar

View all News

Agenda

17
November
London
Social Media in the Defence and Military Sector 2021, 17-18 November, London, UK
Now in its 10th year, SMi Group are pleased to present the Social Media in the Defence and Military Sector conference,...
20
September
United KingdomLondon
Future Armoured Vehicles Power Systems 2021, 20-21 September 2021, London, UK
As the shift from traditional power packs towards alternative means of vehicle propulsion accelerates, and armed forces...
15
September
United KingdomLondon
Defence Exports 2021, 15-16 September 2021, London, United Kingdom
SMi Group are delighted to announce that the fifteenth annual Defence Exports conference will convene on 15th – 16th...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
© 2021 EPICOS
Made by Wedia